US clears Sanofi’s ‘follow-on’ insulin Admelog

12th December 2017 Uncategorised 0

The US Food and Drug Administration has cleared Sanofi’s Admelog, the first follow-on biologic version of Eli Lilly’s Humalog, to manage mealtime blood sugar levels in people with diabetes.

More: US clears Sanofi’s ‘follow-on’ insulin Admelog
Source: News